Company: NDRA
Filing Date: 2025-03-31
Form Type: 10-K
Source: 0001654954-25-003612
Chunk: 152

Company: ENDRA Life Sciences Inc.
Filing Date: 2025-03-31
Form: 10-K
Item: Item 11
Chunk 152
---
 -   -   -   95,900(6)Chief Financial Officer (since August 8, 2024)                      Irina Pestrikova 2024  126,298   -   -   -   126,298 Former Senior Director, Finance (until August 8, 2024) 2023  185,000   29,724   -   -   214,724 

______________

(1) The amounts shown in this column indicate the grant date fair value of option awards granted in the subject year computed in accordance with FASB ASC Topic 718. For additional information regarding the assumptions made in calculating these amounts, see notes 2 and 8 to the financial statements included in Part II, Item 8 of this Annual Report. The shares underlying these option awards vest and become exercisable in three equal annual installments beginning on the first anniversary of their respective grant dates.(2) Represents insurance premiums paid by the Company with respect to life insurance for the benefit of the named executive officer, unless footnoted otherwise.

(3) Prior to appointment as Acting Chief Executive Officer, Mr. Tokman served on the Board and provided consulting services to the Company.  As a Board member, in January 2024, he was awarded an annual option grant to purchase 600 shares with a per share exercise price of $1.59.  This grant was subject to adjustment due to the Company’s August 2024 Reverse Stock Split and the November 2024 Reverse Stock Split.  After adjustment, this grant is for 1 share with a per share exercise price of $2,782.50.  The amount shown above, $954, indicates the grant date fair value of option awards granted in the subject year computed in accordance with FASB ASC Topic 718.  Board fees and consulting fees paid to Mr. Tokman in 2024 total $25,000 and $75,000, respectively.(4)Comprised of severance payments and continued healthcare coverage to Mr. Michelon. See “Employment Agreements and Change of Control Arrangements” for more details on Mr. Michelon’s severance.(5)Mr. Thornton is paid in Canadian Dollars.  This figure is calculated using an average exchange rate of 1.3702 Canadian Dollars to US Dollars.(6)The Company contracts with Impact Solve, LLC (dba Impact Solutions) for Mr. Jac